
Manufacturer and distributor of blood glucose monitoring systems, lancets, lancing devices and medical devices for diabetes therapy

aktivmed GmbH
Rheine (Headquarters)New on Amplifa
About aktivmed
aktivmed GmbH is a MedTech company for medical devices and in vitro diagnostics headquartered in Rheine, North Rhine-Westphalia. Originating from ESKA, the company's history dates back to 1925. Its core competence lies in the distribution of blood glucose monitoring systems of the GlucoCheck series (GOLD, Excellent, XL) as well as pen needles, lancets and lancing devices. With more than 250 employees across the corporate group, aktivmed ranks among the five leading manufacturers of blood glucose test strips on the German market. Another focus is on digital solutions such as the DIAmantApp, DiaBook, DiaCarbs and the BE-App for managing health and nutrition data. The company is certified to DIN EN ISO 13485 and supplies patients, physicians, pharmacies and care staff, among others in cooperation with DAK.
- Site
- Rheine
- Processes
- Blood glucose measurement / In vitro diagnostics (GlucoCheck series: GlucoCheck GOLD, GlucoCheck, Manufacturing/testing of blood glucose test strips (2+2 technology, batch testing by independent, System accuracy testing GlucoCheck XL per DIN EN ISO 15197:2015, Manufacturing of pen needles, lancets and lancing devices, Development of digital solutions (DIAmantApp, DiaBook, DiaCarbs, BE-App), Distribution of blood glucose monitoring systems and accessories, Download area for instructions for use, software and studies, Loyalty campaign/rewards program
- Materials
- Latex, PVC, Visco mineral foam, In Vitro Diagnostics, Medical Devices Class per 93/42/EEC, Digital Health Applications
- Certificates
- DIN EN ISO 13485, DIN EN ISO 15197:2015 (product requirement for GlucoCheck monitoring systems), ISO 13485, ISO 9001, Other (DIN EN ISO 15197:2015)
- Founded
- 1925 (comp
- Employees
- more than 250
- Industries
- MedTech / In Vitro Diagnostics, Diabetes Therapy, Medical Aids (Incontinence, Care, Wound Care), Medical Aids (Incontinence, Care, Wound Care, Gloves)
- 01
Development (monitoring systems, apps)
- 02
Manufacturing/testing of test strips (2+2 technology)
- 03
Manufacturing of pen needles, lancets and lancing devices
- 04
Batch testing by independent German institutes
- 05
Distribution via pharmacies
- 06
Customer service and training for healthcare professionals
Products & Technologies
In Vitro Diagnostics
Blood glucose monitoring systems and test strips per Directive 98/79/EC for diabetes therapy.
Medical Devices Class per 93/42/EEC
Lancing devices, lancets as well as products in the areas of incontinence and wound care.
Digital Health Applications
DIAmantApp, DiaBook, DiaCarbs and BE-App for diabetes management and nutrition documentation.
Locations

Rheine
DEHeadquarters
- Materials
- Blood glucose monitoring systems, test strips, lancets, lancing devices
Products




Inside the production



Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| Blood glucose measurement / In vitro diagnostics (GlucoCheck series: GlucoCheck GOLD, GlucoCheckTesting | – | – | – | – | Blood (capillary blood, fingertip plasma) |
| Manufacturing/testing of blood glucose test strips (2+2 technology, batch testing by independentTesting | 98.3% of measurements <15 mg/dL or <15% (GlucoCheck | – | – | – | – |
| System accuracy testing GlucoCheck XL per DIN EN ISO 15197:2015Testing | 98.8% of measurements <15 mg/dL or <15% | – | – | – | – |
| Manufacturing of pen needles, lancets and lancing devicesAssembly | – | – | – | – | – |
| Development of digital solutions (DIAmantApp, DiaBook, DiaCarbs, BE-App)Engineering | – | – | – | – | – |
Additional services
Reference customers
Quality
aktivmed GmbH is certified to DIN EN ISO 13485. All GlucoCheck monitoring systems comply with the standard DIN EN ISO 15197:2015; every test strip batch is tested during production and subsequently by independent German institutes.
| Evidence | Rheine |
|---|---|
| ISO 13485 | |
| ISO 9001 | |
| Other (DIN EN ISO 15197:2015) |
History
- 1925
Company history begins; originated from ESKA
- 2015
Robin Brünger becomes Managing Director of aktivmed GmbH
- 2024
GlucoCheck GOLD receives an overall rating of GOOD (1.7) from Stiftung Warentest (11/2024)
- 2026
aktivmed becomes Partner Company 2026 of Médecins Sans Frontières (Ärzte ohne Grenzen e. V.)